![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2016-03-23 Option Award | 2016-03-25 4:16 pm | 2016-03-23 2026-03-23 | Akari Therapeutics Plc | AKTX | SHAW ROBERT M General Counsel and Secretary | 1,800,000 | $14.1 | 1,800,000 (Direct) | View |
2016-04-22 Option Award | 2016-04-26 4:31 pm | 2017-04-22 2026-04-22 | Akari Therapeutics Plc | AKTX | Byrne David Director | 1,300,000 | $17.96 | 1,300,000 (Direct) | View |
2016-06-29 Option Award | 2016-06-30 5:08 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Williams Donald Allen Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |
2016-06-29 Option Award | 2016-06-30 5:08 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Williams Donald Allen Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |
2016-06-29 Option Award | 2016-06-30 5:09 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Ungar Stuart Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |
2016-06-29 Option Award | 2016-06-30 5:10 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Hill James Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |
2016-06-29 Option Award | 2016-06-30 5:10 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Byrne David Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |
2016-06-29 Option Award | 2016-06-30 5:11 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Cohen Mark S Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |